Latest Articlesddd
Ionis Pharmaceuticals (IONS) has further good news with a new revelation from Akcea Therapeutics, a wholly-owned …
Prohost Letter #403 Part 2 Continued From Wednesday Instead of continuing yesterday article about Agenus, we …
ProhostLetter #403 Part 1 On December 8, 2016 under News & Comments Prohost commented on President …
Today we have good news and bad news. The good news is coming from Regeneron (REGN)through two …
President Elect Trump was quoted in a Time person of the year as saying “I am …
Bellicum Pharmaceuticals (BLCM) announced results from the BP-004 multicenter clinical trial for children with Primary Immune …
Prohost Letter #402 Antisense Proof of Concept and Feasibility EYE ON INVIVA (INVA) Sales of The …
Prohost Biotech On ARRAY PHARMACEUTICALS Under the title “Halozyme has Good News and Array Too”, we …
Prohost Letter #401 SYNOPSIS PART 1 In this Letter CONTENTS Duchenne Muscular Dystrophy (DMD) FDA Compassionate …
The U.S. Food and Drug Administration (FDA) has removed the partial clinical hold it put on …
The media failure to forecast the results of the Presidential election has become the talk of …
Biogen (BIIB) and Ionis (IONS) announced that Spinraza (nusinersen), an antisense drug designed and developed by …
The nature the Presidential Election this time is weighing on investors’ chests and minds and mood …
Ariad Pharmaceuticals (ARIA): Good news from the U.S. Food and Drug Administration (FDA) affirmed that the …
Regeneron (REGN) and Sanofi informed that the FDA has issued a Complete Response Letter (CRL) regarding …
Prohost Letter #400 NEAR-TERM INVESTING The Prohost Letter #399 Part 3 has Promised to Des
Results from trials were negative in two phase 2 studies for Gilead (GILD) experimental drug GS-4997 …
There is nothing wrong with Nektar Therapeutics (NKTR). The stock is temporarily underperforming as traders are …
At the Annual European Congress of Rheumatology (EULAR 2016) in London, Eli Lilly and Company (LLY) …
Shares of Ariad Pharmaceuticals declined following Senator Bernie Sanders’ criticism of the high price of the …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
